141 related articles for article (PubMed ID: 38336506)
1. Maintenance steroid therapy is associated with decreased risk of malignancy and better prognosis of patients with autoimmune pancreatitis: A multicenter cohort study in Japan.
Takikawa T; Kikuta K; Sano T; Ikeura T; Fujimori N; Umemura T; Naitoh I; Nakase H; Isayama H; Kanno A; Kamata K; Kodama Y; Inoue D; Ido A; Ueki T; Seno H; Yasuda H; Iwasaki E; Nishino T; Kubota K; Arizumi T; Tanaka A; Uchida K; Matsumoto R; Hamada S; Nakamura S; Okazaki K; Takeyama Y; Masamune A;
Pancreatology; 2024 May; 24(3):335-342. PubMed ID: 38336506
[TBL] [Abstract][Full Text] [Related]
2. IgG4-related pancreatobiliary diseases could be associated with onset of pancreatobiliary cancer: A multicenter cohort study.
Kurita Y; Kubota K; Fujita Y; Tsujino S; Sekino Y; Kasuga N; Iwasaki A; Iwase M; Izuka T; Kagawa K; Tanida E; Yagi S; Hasegawa S; Sato T; Hosono K; Kobayashi N; Ichikawa Y; Nakajima A; Endo I
J Hepatobiliary Pancreat Sci; 2024 Mar; 31(3):173-182. PubMed ID: 38124014
[TBL] [Abstract][Full Text] [Related]
3. Steroid Therapy and Steroid Response in Autoimmune Pancreatitis.
Matsubayashi H; Ishiwatari H; Imai K; Kishida Y; Ito S; Hotta K; Yabuuchi Y; Yoshida M; Kakushima N; Takizawa K; Kawata N; Ono H
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31905944
[TBL] [Abstract][Full Text] [Related]
4. Impact of sclerosing dacryoadenitis/sialadenitis on relapse during steroid therapy in patients with type 1 autoimmune pancreatitis.
Ishii Y; Serikawa M; Sasaki T; Fujimoto Y; Yamaguchi A; Ogawa T; Noma B; Okazaki A; Yukutake M; Ishigaki T; Chayama K
Scand J Gastroenterol; 2019 Feb; 54(2):259-264. PubMed ID: 30915865
[TBL] [Abstract][Full Text] [Related]
5. Prognosis of autoimmune pancreatitis.
Kamisawa T; Okamoto A
J Gastroenterol; 2007 May; 42 Suppl 18():59-62. PubMed ID: 17520225
[TBL] [Abstract][Full Text] [Related]
6. Relapse rate and predictors of relapse in a large single center cohort of type 1 autoimmune pancreatitis: long-term follow-up results after steroid therapy with short-duration maintenance treatment.
Lee HW; Moon SH; Kim MH; Cho DH; Jun JH; Nam K; Song TJ; Park DH; Lee SS; Seo DW; Lee SK
J Gastroenterol; 2018 Aug; 53(8):967-977. PubMed ID: 29362937
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic Solid Focal Lesions: Differential Diagnosis between Autoimmune Pancreatitis and Pancreatic Cancer.
Dite P; Novotny I; Dvorackova J; Kianicka B; Blaho M; Svoboda P; Uvirova M; Rohan T; Maskova H; Kunovsky L
Dig Dis; 2019; 37(5):416-421. PubMed ID: 31079114
[TBL] [Abstract][Full Text] [Related]
8. Risks and characteristics of pancreatic cancer and pancreatic relapse in autoimmune pancreatitis patients.
Ishikawa T; Kawashima H; Ohno E; Iida T; Suzuki H; Uetsuki K; Yamada K; Yashika J; Yoshikawa M; Gibo N; Aoki T; Kataoka K; Mori H; Fujishiro M
J Gastroenterol Hepatol; 2020 Dec; 35(12):2281-2288. PubMed ID: 32583452
[TBL] [Abstract][Full Text] [Related]
9. Japanese consensus guidelines for management of autoimmune pancreatitis: III. Treatment and prognosis of AIP.
Kamisawa T; Okazaki K; Kawa S; Shimosegawa T; Tanaka M;
J Gastroenterol; 2010 May; 45(5):471-7. PubMed ID: 20213336
[TBL] [Abstract][Full Text] [Related]
10. Nationwide epidemiological survey of autoimmune pancreatitis in Japan in 2016.
Masamune A; Kikuta K; Hamada S; Tsuji I; Takeyama Y; Shimosegawa T; Okazaki K;
J Gastroenterol; 2020 Apr; 55(4):462-470. PubMed ID: 31872350
[TBL] [Abstract][Full Text] [Related]
11. Steroid treatment response combined with serological mark in differentiating type-1 autoimmune pancreatitis from pancreatic cancer.
Liu B; Tang N; Yao Y; Li H; Xu L; Zhou B; Liu B
Medicine (Baltimore); 2022 Nov; 101(45):e31660. PubMed ID: 36397434
[TBL] [Abstract][Full Text] [Related]
12. Treatment for autoimmune pancreatitis: consensus on the treatment for patients with autoimmune pancreatitis in Japan.
Ito T; Nishimori I; Inoue N; Kawabe K; Gibo J; Arita Y; Okazaki K; Takayanagi R; Otsuki M
J Gastroenterol; 2007 May; 42 Suppl 18():50-8. PubMed ID: 17520224
[TBL] [Abstract][Full Text] [Related]
13. Clinical factors predictive of spontaneous remission or relapse in cases of autoimmune pancreatitis.
Kubota K; Iida H; Fujisawa T; Yoneda M; Inamori M; Abe Y; Kirikoshi H; Saito S; Ohshiro H; Kakuta Y; Nakajima A
Gastrointest Endosc; 2007 Dec; 66(6):1142-51. PubMed ID: 18061714
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous occurrence of autoimmune pancreatitis and pancreatic cancer in patients resected for focal pancreatic mass.
Macinga P; Pulkertova A; Bajer L; Maluskova J; Oliverius M; Smejkal M; Heczkova M; Spicak J; Hucl T
World J Gastroenterol; 2017 Mar; 23(12):2185-2193. PubMed ID: 28405146
[TBL] [Abstract][Full Text] [Related]
15. Clinical features and long-term outcomes of patients with type 2 autoimmune pancreatitis.
de Pretis N; Carlin M; Calderini E; Caldart F; Conti Bellocchi MC; Amodio A; De Marchi G; Campagnola P; Crinò SF; Bernardoni L; Gabbrielli A; Martinelli L; Frulloni L
United European Gastroenterol J; 2024 Apr; 12(3):319-325. PubMed ID: 38217278
[TBL] [Abstract][Full Text] [Related]
16. The M-ANNHEIM-AiP-Activity-Score is useful for predicting relapse in patients with type 1 autoimmune pancreatitis.
Sano T; Kikuta K; Takikawa T; Matsumoto R; Hamada S; Sasaki A; Kataoka F; Ikeda M; Miura S; Kume K; Masamune A
Pancreatology; 2023 Jan; 23(1):112-119. PubMed ID: 36509645
[TBL] [Abstract][Full Text] [Related]
17. The relationship between pancreatic atrophy after steroid therapy and diabetes mellitus in patients with autoimmune pancreatitis.
Masuda A; Shiomi H; Matsuda T; Takenaka M; Arisaka Y; Azuma T; Kutsumi H
Pancreatology; 2014; 14(5):361-5. PubMed ID: 25278305
[TBL] [Abstract][Full Text] [Related]
18. Autoimmune Pancreatitis in Patients with Inflammatory Bowel Disease: A Real-World Multicentre Collaborative ECCO CONFER Study.
Eder P; Verstock B; Culver E; Dragoni G; Kredel LI; Wypych J; de Paredes AGG; Kaniewska M; Leibovitzh H; Lobaton T; Truyens M; Oracz G; Ribaldone DG; Starzyńska T; Badaoui A; Rahier JF; Bezzio C; Bossuyt P; Falloon K; Pugliese D; Frakes Vozzo C; Jess T; Larsen L; Olesen SS; Pal P; Chaparro M; Dror D; Ellul P; Gromny I; Janiak M; Maciejewska K; Peleg N; Bar-Gil Shitrit A; Szwed Ł; Talar-Wojnarowska R; Snir Y; Weisshof R; Zittan E; Miechowicz I; Goren I
J Crohns Colitis; 2023 Nov; 17(11):1791-1799. PubMed ID: 37283545
[TBL] [Abstract][Full Text] [Related]
19. Short-term and long-term outcomes of autoimmune pancreatitis.
Takuma K; Kamisawa T; Tabata T; Inaba Y; Egawa N; Igarashi Y
Eur J Gastroenterol Hepatol; 2011 Feb; 23(2):146-52. PubMed ID: 21287714
[TBL] [Abstract][Full Text] [Related]
20. Is a 2-week steroid trial after initial negative investigation for malignancy useful in differentiating autoimmune pancreatitis from pancreatic cancer? A prospective outcome study.
Moon SH; Kim MH; Park DH; Hwang CY; Park SJ; Lee SS; Seo DW; Lee SK
Gut; 2008 Dec; 57(12):1704-12. PubMed ID: 18583399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
